Covid 19 Research using Clinical Trials (Home Page)
Report for D001988: Bronchiolitis NIH
(Synonyms: Bronchioliti, Bronchiolitis)
Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation
Correlated Drug Terms (4)
| Name (Synonyms) | Correlation | |
|---|---|---|
| drug826 | Educational outreach Wiki | 1.00 |
| drug244 | Audit and Feedback Wiki | 1.00 |
| drug636 | Control Wiki | 0.38 |
| drug2662 | Vitamin C Wiki | 0.30 |
Correlated MeSH Terms (0)
| Name (Synonyms) | Correlation |
|---|
There is one clinical trial.
Clinical Trials
1 Feasibility Pilot of Audit and Feedback With Educational Outreach to Align Continuous Pulse Oximetry Use in Stable Bronchiolitis With Evidence and Guideline Recommendations
The primary objective is to measure the feasibility, acceptability, and appropriateness of audit and feedback with educational outreach as a strategy to align continuous pulse oximetry use in stable bronchiolitis patients with evidence and guideline recommendations.
NCT04178941 Bronchiolitis Behavioral: Audit and Feedback Behavioral: Educational outreach MeSH:Bronchiolitis
HPO:Bronchiolitis
Primary Outcomes
Description: The participant rates the feasibility of the intervention based on 4 statements, with 5 options for each statement ranging from (1) Completely Disagree to (5) Completely Agree.
Measure: 4-item Feasibility of Intervention Measure (FIM) Time: 6 months
Description: The participant rates the acceptability of the intervention based on 4 statements, with 5 options for each statement ranging from (1) Completely Disagree to (5) Completely Agree.
Measure: 4-item Acceptability of Intervention Measure (AIM) Time: 6 months
Description: The participant rates the appropriateness of the intervention based on 4 statements, with 5 options for each statement ranging from (1) Completely Disagree to (5) Completely Agree.
Measure: 4-item Intervention Appropriateness Measure (IAM) Time: 6 months
Secondary Outcomes
Description: Continuous pulse oximetry use rates in children with bronchiolitis who are not requiring supplemental oxygen administration.
Measure: Continuous pulse oximetry use rates Time: 6 months
Description: This measure will be calculated using chart review (to determine presence of electronic health record data from the medical monitoring device) and direct observation (to determine actual monitoring at the bedside).
Measure: Sensitivity of the presence of electronic health record data from the medical monitoring device for actual monitoring at the bedside in bronchiolitis. Sensitivity is also referred to as the "true positive rate." Time: 6 months
Description: This measure will be calculated using chart review (to determine presence of electronic health record data from the medical monitoring device) and direct observation (to determine actual monitoring at the bedside).
Measure: Specificity of the absence of electronic health record data from the medical monitoring device for absence of monitoring at the bedside in bronchiolitis. Specificity is also referred to as the "true negative rate." Time: 6 months
Description: This measure will be calculated using chart review (to determine presence of electronic health record data from the medical monitoring device) and direct observation (to determine actual monitoring at the bedside).
Measure: Positive predictive value of the presence of electronic health record data from the medical monitoring device for actual monitoring at the bedside in bronchiolitis. Time: 6 months
Description: This measure will be calculated using chart review (to determine presence of electronic health record data from the medical monitoring device) and direct observation (to determine actual monitoring at the bedside).
Measure: Negative predictive value of the absence of electronic health record data from the medical monitoring device for absence of monitoring at the bedside in bronchiolitis. Time: 6 months
HPO Nodes
Primary Outcomes
Description: The participant rates the feasibility of the intervention based on 4 statements, with 5 options for each statement ranging from (1) Completely Disagree to (5) Completely Agree.
Measure: 4-item Feasibility of Intervention Measure (FIM) Time: 6 monthsDescription: The participant rates the acceptability of the intervention based on 4 statements, with 5 options for each statement ranging from (1) Completely Disagree to (5) Completely Agree.
Measure: 4-item Acceptability of Intervention Measure (AIM) Time: 6 monthsDescription: The participant rates the appropriateness of the intervention based on 4 statements, with 5 options for each statement ranging from (1) Completely Disagree to (5) Completely Agree.
Measure: 4-item Intervention Appropriateness Measure (IAM) Time: 6 monthsSecondary Outcomes
Description: Continuous pulse oximetry use rates in children with bronchiolitis who are not requiring supplemental oxygen administration.
Measure: Continuous pulse oximetry use rates Time: 6 monthsDescription: This measure will be calculated using chart review (to determine presence of electronic health record data from the medical monitoring device) and direct observation (to determine actual monitoring at the bedside).
Measure: Sensitivity of the presence of electronic health record data from the medical monitoring device for actual monitoring at the bedside in bronchiolitis. Sensitivity is also referred to as the "true positive rate." Time: 6 monthsDescription: This measure will be calculated using chart review (to determine presence of electronic health record data from the medical monitoring device) and direct observation (to determine actual monitoring at the bedside).
Measure: Specificity of the absence of electronic health record data from the medical monitoring device for absence of monitoring at the bedside in bronchiolitis. Specificity is also referred to as the "true negative rate." Time: 6 monthsDescription: This measure will be calculated using chart review (to determine presence of electronic health record data from the medical monitoring device) and direct observation (to determine actual monitoring at the bedside).
Measure: Positive predictive value of the presence of electronic health record data from the medical monitoring device for actual monitoring at the bedside in bronchiolitis. Time: 6 monthsDescription: This measure will be calculated using chart review (to determine presence of electronic health record data from the medical monitoring device) and direct observation (to determine actual monitoring at the bedside).
Measure: Negative predictive value of the absence of electronic health record data from the medical monitoring device for absence of monitoring at the bedside in bronchiolitis. Time: 6 months